Erste Asset Management’s Immunogen Inc IMGN Stock Holding History

Erste Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-63,000	Closed	-$1.87M	–	585
2023 Q4	$1.87M	Buy	63,000 +16,000	+34%	+$319K	0.03%	300
2023 Q3	$752K	Hold	47,000	–	–	0.01%	371
2023 Q2	$883K	Hold	47,000	–	–	0.02%	375
2023 Q1	$174K	Hold	47,000	–	–	﹤0.01%	498
2022 Q4	$243K	Hold	47,000	–	–	0.01%	482
2022 Q3	$221K	Hold	47,000	–	–	﹤0.01%	491
2022 Q2	$205K	Hold	47,000	–	–	﹤0.01%	510
2022 Q1	$223K	Buy	+47,000	New	+$260K	﹤0.01%	499

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Erste Asset Management's IMGN Position: Q1 2024 in Review

Erste Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 63,000 shares — an estimated $1.87M sold.

Erste Asset Management first reported a position in IMGN in Q1 2022 and held it in 8 quarters. The position peaked at $1.87M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Erste Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Erste Asset Management sold 63,000 Immunogen Inc shares in Q1 2024, an estimated $1.87M.
Erste Asset Management first reported a position in Immunogen Inc in Q1 2022 and held it in 8 quarters.
Erste Asset Management's Immunogen Inc position peaked at $1.87M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.